Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Person › Details

Gregory Gin (Affimed N.V. (Nasdaq: AFMD))

Gin, Gregory (Affimed 201808 Head of Investor Relations)


Organisation Organisation Affimed N.V. (Nasdaq: AFMD)
  Group Affimed (Group)
Products Product public relations / investor relations / marcom (services)
  Product 2 cancer immunotherapy (immuno-oncology, I-O)

Affimed N.V.. (8/30/18). "Press Release: Affimed to Present at the 2018 Wells Fargo Securities Healthcare Conference". Heidelberg.

Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies that harness the power of innate and adaptive immunity (NK and T cells), today announced that Dr. Adi Hoess, Affimed’s CEO, will present at the 2018 Wells Fargo Securities Healthcare Conference on Thursday, September 6, 2018 at 8:35 a.m. ET in Boston.

A live webcast of the conference presentation can be accessed through the “Events” section on the “Investors & Media” page of the Affimed website at A replay of the presentation will be available from Affimed’s website for 30 days following the conference.

About Affimed N.V.

Affimed (Nasdaq: AFMD) engineers targeted immunotherapies, seeking to cure patients by harnessing the power of innate and adaptive immunity (NK and T cells). We are developing single and combination therapies to treat cancers and other life-threatening diseases. For more information, please visit

Affimed Investor Contact:
Gregory Gin, Head of Investor Relations

Affimed Media Contact:
Anca Alexandru, Head of Communications, EU IR

Record changed: 2019-05-30


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Gregory Gin

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture [iito] Back into Ad 650x80px

» top